.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
Express Scripts
Baxter
Dow
McKinsey
Covington
Boehringer Ingelheim
Argus Health
Novartis

Generated: December 17, 2017

DrugPatentWatch Database Preview

OVIDREL Drug Profile

« Back to Dashboard

Summary for OVIDREL

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 23
Drug Prices:see details
DailyMed Link:OVIDREL at DailyMed
Drug patent expirations by year for OVIDREL

Pharmacology for OVIDREL

Ingredient-typeGonadotropins
Drug ClassGonadotropin

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd SeronoOVIDRELchoriogonadotropin alfaINJECTABLE;INJECTION021149-001Sep 20, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Emd SeronoOVIDRELchoriogonadotropin alfaINJECTABLE;SUBCUTANEOUS021149-002Oct 6, 2003RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: OVIDREL

Country Document Number Estimated Expiration
Portugal814841► Subscribe
World Intellectual Property Organization (WIPO)9629095► Subscribe
Finland973745► Subscribe
Austria209930► Subscribe
Australia707796► Subscribe
Norway974309► Subscribe
Ukraine61053► Subscribe
Brazil9510567► Subscribe
Germany69524456► Subscribe
Spain2166841► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: OVIDREL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB01/030United Kingdom► SubscribePRODUCT NAME: RECOMBINANT CHORIOGONADOTROPIN ALFA; REGISTERED: UK EU/1/00/165/001-006 20010202
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
US Army
QuintilesIMS
Chubb
Express Scripts
Novartis
US Department of Justice
Moodys
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot